期刊文献+

伊布利特的临床和电生理学研究进展

Clinical and Electrophysiological Study on Ibutilide
下载PDF
导出
摘要 伊布利特是一种新型的Ⅲ类抗心律失常药物,临床主要用于心房颤动、心房扑动的转复,具有疗效显著、不良反应相对较小等优点,伊布利特的临床疗效优于普罗帕酮,与氟卡胺、胺碘酮疗效相近,伊布利特与普罗帕酮、胺碘酮、电复律、镁剂联用可提高临床疗效。 Ibutilide is a novel class Ⅲ antiarrhythmic agent, which is effective in the terminatian of atrial flutter and atrial fibrillation with rare complications and without long-term adverse effects. It is demonstrated that the clinical effects of ibutilide is better than those of propafenane,but its effects is similar to that of flecainide or amiedarone. After being combined with propafenone, amiedarone, internal atrial cardioversion or magnesium, its effects would be raised.This article reviewed the mechanisms, clinical applications, potential complications, and appropriate use of ibutilide.
作者 冯霞 何振山
出处 《医学综述》 2008年第5期757-759,共3页 Medical Recapitulate
关键词 心律失常 伊布利特 心房颤动 心房扑动 尖端扭转性室性心动过速 Arrhythmia Ibutilide Atrial fibrillation Atrial flutter Torsades de pointes
  • 相关文献

参考文献16

  • 1Wood MA, Stambler KS, Ellenbogen KA, et al. Suppression of inducible ventricular tachycardia by ibutilide in patients with coronary artery disease. Ibutilide Investigators[J]. Am Heart J, 1998,135(6 Pt 1 ) : 1048-1054.
  • 2Abi-Mansour P, Carberry PA, Mccowan RJ,et al. Conversion efficacy and safety of repeat doses of ibtilide in patients with atrial flutter and atrial fibrillation. Study investigators[J]. Am Heart J, 1998, 136(4 Pt 1 ) : 632-642.
  • 3Das MK, Cheriparambil K, Bedi A, et al. Cardioversion of atrial fibrillation with ibutilide: when is it most effective? [J]. Clin Cardiol, 2002,25(9) :411-415.
  • 4Gowda RM, Khan IA, Punukollu G, et al. Use of ibutilide for cardioversion of resent-onset atrial fibrillation and flutter in elderly[J]. Am J Ther, 2004,11(2) :95-97.
  • 5Delle Karth G, Schillinger M, Geppert A, et al. Ibutilide for rapid conversion of atrial fibrillation or flutter in a mixed critical ill patient population[ J ]. Wien Klin Wochenschr, 2005,117 ( 3 ) : 92-97.
  • 6Glatter KA, Dorostkar PC, Yang Y, et al. Electrophysiological effects of ibutilide in patients with accessory pathways[J]. Circulation,2001,104 (16) : 1933-1939.
  • 7Reisinger J,Gatterer E, Lang W, et al. Flecainide versus ibutilide for immediate cardioversion of atrial fibrillation of recent onset [ J ]. Eur Heart J,2004,25(15) :1318-1324.
  • 8Bernard EO, Schmid ER, Schmidlin D, et al. Ibutilide versus amiodatone in atrial fibrillation: a double-blinded, randomized study [ J ]. Crit Care Med,2003,31 (4) : 1031-1034.
  • 9Tai CT, Chen SA, Feng AN, et al. Electropharmacologic effects of class Ⅰ and class Ⅲ antiarrhythmia drugs on typical atrial flutter: insights into the mechanism of termination [ J ]. Circulation, 1998, 97 ( 19 ) : 1935-1945.
  • 10孙健玲,郭继鸿,张海澄.伊布利特和普洛帕酮转复心房扑动的疗效观察[J].中国实用内科杂志,2005,25(2):137-138. 被引量:21

二级参考文献2

  • 1Gowda RM, Ptmukollu G, Khan IA, et al. Ibutilide for pharmacological cardioversion of atrial fibrillation and flutter:impact of race on efficacy and safety. Am J Ther,2003,10(4) :259-263.
  • 2Hongo RH, Themistoclakis S, Raviele A, et al. Use of ibutilide in cardioversion of patients with atrial fibrillation or atrial flutter treated with classic IC agents. J Am Coll Cardiol, 2004, 44 (4) :864-868.

共引文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部